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Herein, we describe a simple, highly efficient and environmentally friendly protocol for the 
synthesis of benzimidazoles, benzoxazoles, benzothiazoles,  3,4-dihydropyrimidin-2-ones/ thiones 
and quinoxalines derivatives using hybrid crystal NH3(CH2)6NH3SiF6 as a catalyst. Use of 
recyclable catalyst, easy work-up procedure, excellent yields, short reaction times and scalability 
are the important practical features of the present protocol.  
________________________________________________________________________________ 
Introduction 
The quinoxaline derivatives have found 
applications as as antiviral, anti- inflammatory, 
antibacterial, kinase inhibitory properties, 
antiprotozoal, antibiotics such as echinomycin, 
leromycin and actinomycin [1-4]. As well, 
quinoxaline moieties have found applications in 
macrocyclic receptors [5], building blocks in the  
 
synthesis of organic semiconductors [6-7], and 
DNA cleaving agents [8]. In late years, several 
synthetic strategies have been developed for the 
preparation of quinoxalines using diverse 
catalysts such as Fe3O4@SiO2-imid-PMA
n 
magnetic porous nano sphere [9], ZrO2 
Al2O3[10], nanoparticle-supported Cobalt (Co 
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NPs) [11], RHA-SO3[12], cell-[pmim]HSO4 
[13], VOSO4 [14]. 
Compounds bearing benzimidazole, 
benzoxazole and benzothiazole moieties are of 
great interest in medicinal area, as they show 
various and significant biological and 
pharmacological attributes such as antibiotic, 
anti- inflammatory, anti-parasitic, anti-stress, 
ulcer, anticancer, gram-positive antibacterial 
and antiviral attributes [15]. In recent times, 
several catalysts and reagents such as Fe(III)-
schiff base/SBA-15 [16] and PSA [17] have 
been reported for the synthesis of 
benzimidazole, benzoxazole and benzothiazole. 
The 3,4-dihydropyrimidin-2-ones/thiones, 
which have been synthesized by a 
multicomponent reaction, are very important 
heterocyclic motif in the realm of natural and 
synthetic organic chemistry due to possessing 
different biological and pharmacological 
activities, such as antibacterial [18], 
antitumor[19] and antiviral [20] properties. 
Several improved methods have been reported 
for the preparation of 3,4-dihydropyrimidin-2-
(1H)-ones/thiones using various catalysts such 
as [Et3N-SO3H]HSO4 [21], calix[8]arene 
sulfonic acid [22], sulfated polyborate [23], 
nano-YAl2O3:Eu
3+ [24], Fe3O4/SiO2-NH-ligand-
Bi(III) nano catalyst [25], Fe3-xTixO4@SO3H 
[26], TiCl3OTf-[bmim]Cl [27], [Dsbim]Cl [28] 
and Cr(NO3)3·9H2O [29]. 
Based on this knowledge and in 
continuation of our work [30] towards 
development of simple, mild, eco-friendly 
reaction protocol, we explored the potential of 
NH3(CH2)6NH3SiF6 as a catalyst for the 
synthesis of benzimidazoles, benzoxazoles, 
benzothiazoles, 3,4-dihydro pyrimidin-2-ones/ 
thiones and quinoxalines. 
 
Results and Discussion  
General information for the catalyst 
The hexylenediammonium hexafluoro 
silicate NH3(CH2)6NH3SiF6 single crystal has 
been synthesised by slow evaporation of 
aqueous solution containing NH2(CH2)6NH2 and 
H2SiF6 [31]. This compound belong to the 
family of alkylenediammoniums halogeno 
metallates compounds of the general formula 
NH3(CH2)nNH3MX6 (IV) (M: Sn, Si, Te; X: Cl, 
Br, I and F) that have attracted more attention 
because of their important chemical and 
physical properties [32]. Some of these 
compounds have been found to be interesting 
for the study of crystal dynamic and phase 
transition involving hydrogen bonds as well as 
the reorientation motions of alkylammoniums 
cations [33]. NH3(CH2)6NH3SiF6 was 
characterized by X-ray diffraction analysis. The 
catalyst was crystallized in the triclinic system 
with 1P (Z = 4) as space group [a = 5.8965 (2) 
Å, b = 13.6946 (5) Å, c = 14.4945 (5) Å;  = 
91.379 (2)°,  = 93.8 4 (1)°, γ = 90.906 (2)° and 
V = 1168.53 (7) Å3]. All characteristic structural 
data of this compound have been recently 
published [31].  
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The crystal structure of this compound has 
been found to be built up from inorganic anions 
SiF6
2- that were arranged to form sheets parallel 
to (001), which are linked into a three-
dimensional network by the organic cations 
+NH3(CH2)6NH3
+ through intermolecular N-
H….F hydrogen bonding contacts (Figure 1) 
that provide a linkage between cationic 
+NH3(CH2)6NH3
+ and SiF6
2- anionic entities. 
The hydrogen bonds involved (donors and 
acceptors) ensure the three-dimensional 
cohesion of the atomic arrangement.  
The symmetry codes : (i) –x, 1−y,  −z ; (ii) 
−x, 2−y, −z ; (iii) −x, 1−y, 1−z ; (iv) −x, 2−y, 
1−z. The asymmetric unit cell of 
NH3(CH2)6NH3SiF6 salt consists of one anion 
(Si1) and one cation together with half of each 
of two cations and two anions (Si2) and (Si3) 
located on inversion centers. 
 
Figure 1. The three dimensional plot of the 
NH3(CH2)6NH3SiF6 compound, showing inorganic sheets 
linked through N–H….F hydrogen bonds to the organic 
layers (dashed lines). 
 
 
In the crystal structure of this compound,  
two silicon atoms [Si2 (0, 1/2, 1/2); Si3 (0, 0, 
0)] are located at inversion centers of the 1P  
space group. Each silicon atom is surrounded by 
six fluorine anions in a slightly distorted SiF6
2- 
octahedral geometry. The unit cell contains one 
hexylenediammonium cation and two halves of 
cations located about an inversion centre. The 
organic cations fill the space between the 
inorganic sheets, forming a three-dimensional 
network by N-H….F hydrogen bonds.  
 
The catalytic activity of Catalyst 
1. Synthesis of benzimidazole 3, benzoxazole 4 
and benzothiazole 5. 
 
At first, the condensation reaction 
between benzaldehyde 1a with 1,2-
phenylenediamine 2a was studied as a model 
reaction (Scheme 1) and the optimization of the 
reaction conditions was performed using various 
amounts of NH3(CH2)6NH3SiF6 in various 
solvents at room temperature. As shown in 
Table 1, in the absence of a catalyst, only 12% 
yield of the desired product was obtained even 
after longer reaction time (Table 1, entry 1). 
Solvent- free conditions at room temperature 
using 1 mol % (2.60 mg) of catalyst (Table 1, 
entry 13) are the best condition for this reaction.  
The generality of the described protocol was 
explored by reacting different substituted 
aromatic aldehydes with o-phenyl  
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enediamine, o-aminothiophenol or o-amino 
phenol. The reaction affords respectively 
benzimidazole 3, benzoxazole 4 and 
benzothiazole 5 (Scheme 1) in good to excellent 
yields in shorter times (Table 2).  
 
Table 1. The effect of  solvent and different amounts of 
NH3(CH2)6NH3SiF6 on the synthesis of benzimidazole 3a
a
 
Entry  Catalyst 
(mol%) 
Solvent (1 
mL) 
Time
b
 
(min) 
Yield 
(%)
c
 
1 - EtOH 240 12 
2 5 EtOH 15 90 
3 5 MeOH 20 91 
4 5 Butanol 55 60 
5 5 Isopropanol 35 76 
6 5 CH3CN 60 71 
7 5 THF 100 62 
8 5 AcOEt  30 84 
9 5 Solvent free  6 92 
10 4 Solvent free  6 93 
11 3 Solvent free  4 93 
12 2 Solvent free  4 95 
13 1 Solvent free  4 96 
aReaction conditions: Benzaldehyde 1a (1 mmol), o-phenylene 
diamine 2a (1 mmol), room temperature.  bTime reported in min 
monitored by thin layer chromatography (TLC). cIsolated yield. 
+
H
O
1                         2                                                                   3. X= NH
                                                                                                4. X= O
                                                                                                5. X= S
1 mol% catalyst
Solvent free, r.t
R
NH2
XH X
N R
  
Scheme 1. Synthesis of compounds 3, 4 and 5 derivatives 
catalyzed by NH3(CH2)6NH3SiF6 . 
 
2. Synthesis of 3,4-dihydropyrimidin-2-thione 
and 3,4-dihydropyrimidin-2-ones/thiones 8.  
 To standardize the reaction conditions, a 
model reaction of benzaldehyde 1a, 
acetylacetone 6a and urea 7a was initially 
carried out under different conditions in the 
presence of catalytic amount of 
NH3(CH2)6NH3SiF6 (Scheme 2, Table 3). 
 
Table 2. NH3(CH2)6NH3SiF6 catalyzed synthesis of 
benzimidazo le, benzothiazo les and benzoxazoles
a
. 
aIsolated yields. bTime reported in min monitored by TLC. 
 
Table 3. Optimization of catalyst amount and solvent in 
the synthesis of pyrimidine-2-one 8a
a
. 
Entry  Catalyst 
(mol%) 
Solvent 
(1 mL) 
Time
b
 
(min) 
Yield (%)
c
 
1 without EtOH 45 39 
2 4 MeOH 10 84 
3 4 Butanol 33 67 
4 4 Isoprop
anol 
11 64 
5 4 CH3CN 14 54 
6 4 THF 26 45 
7 4 AcOEt  24 45 
8 4 EtOH 7 91 
9 3 EtOH 7 92 
10 2 EtOH 7 95 
12 1 EtOH 7 94 
aReaction conditions:: benzaldehyde 1a (1 mmol), acetoacetate 
6a (1 mmol) and urea 7a (1.5 mmol),  NH3(CH2)6NH3SiF6 , 1mL 
solvent, at 40°C.   bTime reported in min monitored by thin layer 
chromatography (TLC).   cIsolated yield 
 It was found that only a 39% amount of 
product 8a was obtained in the absence of 
catalyst even after 45 min (Table 3, entry 1). It 
Product R X Time
b
 (min) Yield
a
(%) 
3a H NH 4 96 
3b 4-Cl NH 4 94 
3c 4-Me NH 6 92 
3d 4-NO2  NH 2 98 
4a H O 7 98 
4b 4-Cl O 5 95 
4c 4-Me O 7 98 
4d 4-NO2  O 5 96 
4e 2-OH O 2 99 
5a H S 6 93 
5b 4-Cl S 6 90 
5c 4-Me S 5 90 
5d 4-NO2  S 7 97 
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was found that the best condition is using 2 mol 
% of the catalyst under EtOH at 40°C (Table 3, 
entry 10). 
A general method has now been 
developed for the synthesis of 3,4-
dihydropyrimidin-2-thione and 3,4-dihydro 
pyrimidin-2-one 8a-j catalyzed by 
NH3(CH2)6NH3SiF6  as a heterogeneous catalyst 
(Scheme 2), the obtained results are summarized 
in Table 4. In all the cases the corresponding 
3,4-dihydropyrimidin-2-thione and 3,4-dihydro 
pyrimidin-2-one 8a-j were obtained in good to 
excellent yield (90-99%) after 2-50 min. 
 
3. Synthesis of quinoxalines 10. 
Initially, the condensation of o-phenylene 
diamine 2a with benzile 9 was used as model 
reaction (Scheme 3). We investigated the effect 
of various solvents (EtOH, MeOH and water) 
and catalyst amounts (1-5 mol %) at room 
temperature for optimization the conditions 
(Table 5).  
+
H
O
1                         6                         7                                                                      8a-j
2 mol % catalyst
N
H
NH
X
R1
O
R1
O
O
+ H2N NH2
X
1 mL EtOH, 40°C
R
R
 
Scheme 2. Synthesis of 3,4-d ihydropyrimid in-2-one/ 
thione 8a-j catalyzed by NH3(CH2)6NH3SiF6. 
It was found that only 47% yield of 
product 10a was obtained when grinding for 10 
minutes in the absence of any catalyst (Table 5, 
entry 1). The best result was achieved by 
carrying out the condensation in the presence of 
1 mol% (2.60 mg) of NH3(CH2)6NH3SiF6 in 1 
mL methanol ( Table 5, entry 10). 
 
Table 4. Synthesis of 3,4-d ihydropyrimid in-2-thione and 
3,4-dihydropyrimid in-2-one 8a-h catalyzed by 
NH3(CH2)6NH3SiF6. 
Product 
 
R 
 
R1 X Time
b
 
(min) 
 
Yield
a
 % 
 
8a H Me O 7  95 
8b H OEt O 45  90 
8c Cl OEt O 45  91 
8d Cl OEt S 50  90 
8e NO2  OEt O 12  99 
8f MeO OEt O 30  98 
8g MeO OEt S 15  95 
8h N(Me)2  OEt O 2   92 
aIsolated yields. bTime reported in min monitored by TLC. 
 
Table 5. Optimization of  the reaction conditions for the 
synthesis of 2,3-diphenylquinoxaline 10a.
 a
 
Entry  Catalyst 
(mol%) 
Solvent 
(1 mL) 
Time
b
 
(min) 
Yield (%)
c
 
1 - EtOH 10 47 
2 5 EtOH 3 87 
3 5 H2O 11 43 
4 5 MeOH 2 90 
5 4 MeOH 2 92 
6 3 MeOH 2 93 
7 2 MeOH 2 93 
8 1 MeOH 2 93 
aReaction conditions: o-phenylenediamine 2a (1 mmol) and 
benzile 9 (1 mmol), room temperature.  bTime reported in min 
monitored by thin layer chromatography (TLC). cIsolated yield. 
  
 To examine the generality of this 
methodology, various 1,2-diamine derivatives 2 
were reacted with benzile 9 (Scheme 3). As 
evident from the table, most of the examined 
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substrates provide good to excellent yields of 
compounds 10a-c in shorter times (Table 6). 
 
+
2                              9                                                                   10a-c
1 mol % catalyst
O
ONH2
NH2
N
N1 mL MeOH, r.t.R R
 
 
Scheme 3. Reaction of benzile with 1,2-diamine 
catalyzed by NH3(CH2)6NH3SiF6. 
 
All prepared products  are known 
compounds [16,34-40] and were identified by 
comparing their 1H NMR and 13C NMR data 
with authentic samples reported in the literature.  
The recycling of the catalyst was also 
studied. For this, the catalyst was filtered, 
separated, washed with methanol and dried at 
80°C for 45 min and then the residual catalyst as 
such was reused without loss of any significant 
catalytic activity. The structure and aspect of the 
catalyst remains unchanged after recovery and 
reuse. We observed that the recovered catalyst 
could be used for six successive runs with a 
slight decrease in activity as indicated in Table 
7. The reusability of the catalyst was also 
investigated on the models reactions for the 
synthesis of compounds 3a, 8a and 10a.  
 
Table 6. Condensation of 1,2-phenylenediamine 2 with 
benzile 9 catalyzed by NH3 (CH2)6NH3SiF6 in MeOH at 
room temperature. 
Product R Time
b
 (min) Yield
a
 % 
10a H 2 93 
10b Me 3 94 
10c NO2  7 99 
aIsolated yields. bTime reported in min monitored by TLC. 
 
Table 7. Recycling of  NH3(CH2)6NH3SiF6  in the 
synthesis of  the compounds 3a, 8a and 10a 
Run   3a      8a  10a 
Time 
(min) 
Yield 
(%)
a
 
Time 
(min) 
Yield 
(%)
a
 
Time 
(min) 
Yield 
(%)
a
 
1 4 96 7 95 2 93 
2 4 96 7 95 2 93 
3 4 94 7 94 2 91 
4 4 90 7 92 2 90 
5 4 90 7 90 2 90 
6 4 90 7 90 2 89 
aIsolated yield. 
In order to compare the efficiency of our 
catalyst with respect to the other catalysts [9-
12,18,22-26,41-42] reported for the synthesis of 
benzimidazole, benzothiazole, benzoxazole, 3,4-
dihydro pyrimidin-2-thione, 3,4-dihydro 
pyrimidin-2-one and quinoxaline, the results are 
tabulated in Table 8. As it is clear from Table 8, 
NH3(CH2)6NH3SiF6 has remarkably improved 
the synthesis of these compounds in different 
terms (reaction time, yield and amount of 
catalyst). 
 
Conclusions  
In conclusion, we have developed an 
highly yield, environmentally friendly and mild 
condition protocol for the synthesis of 
medicinally important heterocycles such as the 
quinoxalines, benzimidazoles, benzoxazoles, 
benzothiazoles and  3,4-dihydropyrimidin-2-
ones/thiones catalyzed by hybrid crystal  
NH3(CH2)6NH3SiF6 under solvent- free or 
ecological solvent conditions. To our delight, 
NH3(CH2)6NH3SiF6 catalyzed reactions not only 
required shorter reaction times but also provided 
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the desired products in good to excellent yields 
with low catalyst loading. 
 
Table 8. Comparison of NH3(CH2)6NH3SiF6 with the 
reported catalysts for the synthesis of these compounds. 
Catalyst 
Ref.
 Conditions Time 
(min) 
Yield 
% 
NH3(CH2)6NH3SiF6  1 mol% 
solvent free, 
rt 
2-7  90-99 
CuO-np/SiO2 [41] 10 mol %, 
10 mL, 
MeOH, rt  
240-840  68–93 
ZnO PNs
 
[34] 5 mg; 
solvent free, 
or in EtOH, 
rt 
2-8  90–99 
CeO2 NPs
 
[42] 10 mol%, 
H2O, rt 
20-40  58–97 
NH3(CH2)6NH3SiF6  2 mol%,  
1 mL EtOH, 
100 °C 
2-50  90-99 
[Et3N–SO3H]HSO4
 
[22] 
(0.014g, 
0.05 mmol), 
solvent free, 
70 °C 
15-100  86-98 
Calix[8]arene 
sulfonic acid
 
[23] 
0.2 mol%,  
3 mL EtOH, 
reflux 
20-48  67-93 
Sulfated polyborte 
[24] 
5wt%, 
solvent free, 
100°C 
20-45  83-94 
NanoYAl2O3:Eu
3+ 
[25] 
2.5 mmol, 
5 mL EtOH, 
80°C 
110  71-92 
Fe3O4/SiO2-NH-
ligand -Bi(III) 
nano catalyst [26] 
0.05g, 
solvent free, 
100 °C 
30  70-95 
NH3(CH2)6NH3SiF6 1 mol%,  
1 mL 
MeOH, rt  
2-7  93-99 
Fe3O4@SiO2-imid-
PMA
 
 magnetic 
porous 
nanosphere
 
[9] 
0.03 g, 0.5 
mol%, 5 mL 
EtOH, rt  
5-25  89-95 
ZrO2-Al2O3
 
[10] 0.03g,  
10 mL 
EtOH, 80°C 
20  90-91 
Co NPs
 
[11] 1 mol %,  
5 mL EtOH, 
rt 
90  88-98 
RHA-SO3H
 
[12] 15 mg, 
solvent free, 
rt 
5-30  90-98 
Experimental part 
Materials 
All the chemicals used were purchased from 
Sigma-Aldrich and were used as such. All 
products are known, and were identified by 
comparison of spectral and physical data with 
the literature. Melting points were measured 
with a Buchi melting-point apparatus and are 
uncorrected. 1H NMR (300 MHz) and 13C 
NMR(75 MHz) spectra were recorded on a 
Brucker spectrometer in DMSO-d6.  
 
General procedure for the synthesis of 
catalyst: The catalyst single crystal has been 
recently synthesized by slow evaporation of 
aqueous solution containing NH2-(CH2)6NH2 
and H2SiF6 by the following method: the solid 
hexane-1,6-diamine NH2(CH2)6NH2 (percentage 
≥ 99%) was primarily dissolved in the necessary 
distilled water and then was mixed with the 
stoichiometric amounts (1:1) to H2SiF6 
(percentage = 34% in weight).  
The obtained solution was taken under 
room temperature for evaporation. The colorless 
single crystals were so obtained (Yield 85%). 
 
General procedure for the preparation of 
benzimidazoles 3, benzoxazoles 4 and 
benzothiazoles 5: Aldehyde (1 mmol), o-phenyl 
enediamine, o-amino thiophenol or o-amino 
phenol (1 mmol) and 1 mol % (2.60 mg) of 
NH3(CH2)6NH3SiF6 were stirred, in free solvent 
conditions, at room temperature for the 
appropriate time (Table 3). The progress of the 
reaction was monitored by TLC hexane/ethyl 
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acetate (70:30) as eluent. After completion of 
the reaction, the crude reaction mixture was 
dissolved in EtOH, and the catalyst was 
separated out by simple filtration. The product 
was recrystallized from ethanol to give 
respectively benzimidazoles 3, benzoxazoles 4 
and benzothiazoles 5 in high yields (90–98%, 
Table 3). 
2-phenyl-1H-benzimidazole 3a.  Yield 
98%. M.p.: 291-292 oC (Lit.[16] 292-294 oC). 
1H NMR δ 12.93 (s, 1H, NH); 7.17-8.18 (m, 9H, 
ArH). 13C NMR δ 151.7; 144.3; 135.5; 130.6; 
130.3; 129.4; 126.9; 123.0; 122.2; 119.3; 111.8. 
2-(4-chlorophenyl)-1H-benzimidazole 3b 
Yield 97%. M.p.: 287-289 oC (Lit.[16] 288-290 
oC). 1H NMR δ 12.99 (s, 1H, NH); 7.19-8.18 
(m, 8H, ArH). 13C NMR δ 150.6; 135.0; 131.2; 
129.5; 129.4; 129.3; 128.8; 128.6; 123.3;  119.4; 
111.9. 
2-(p-tolyl)-1H-benzimidazole 3c. Yield 
95%. M.p.: 276-278 oC (Lit.[16] 275-276 oC). 
1H NMR δ 12.80 (s, 1H, NH), 7.15-8.06 (m, 8H, 
ArH); 2.35 (s. 3H. CH3). 
13C NMR δ 151.9; 
140.1; 129.9; 129.8; 129.5; 127.9; 126.8; 126.4; 
122.8; 119.1; 111.6; 21.4. 
2-(4-nitrophenyl)-1H-benzimidazole 3d. 
Yield 99%. M.p.: 317-319 oC (Lit.[16] 318-320 
oC). 1H NMR δ 8.81 (s, 1H, NH); 6.52-8.40 (m, 
8H, ArH). 13C NMR δ 153.9; 148.8; 145.4; 
142.8; 134.4; 129.9; 129.3; 127.9; 124.3; 117.5; 
115.5. 
2-phenyl benzoxazole (4a). Yield 98%. 
M.p.:100-102oC (Lit.[34] 100-102 oC). 1H NMR 
δ 6.79-8.03 (m, 9H, ArH). 
13C NMR δ 159.8; 
151.6; 138.4; 136.8; 131.7; 129.9; 129.6; 129.3; 
127.8; 119.9; 116.4. 
2-(4-chlorophenyl) benzoxazole 4b. Yield 
97%. M.p.: 144-145 oC (Lit.[34] 144-146 oC). 
1H NMR δ 6.78-8.05 (m, 8H, ArH). 
13C NMR δ 
158.3; 151.8; 137.9; 136.2; 135.7; 130.9; 129.2; 
129.1; 128.1; 119.5; 116.9. 
2-(p-tolyl) benzoxazole 4c. Yield 96%. 
M.p.: 88-90 oC (Lit.[34] 88-89 oC). 1H NMR δ 
6.79-7.56 (m, 8H, ArH); 2.33 (s, 3H, CH3). 
13C 
NMR δ 159.5; 151.6; 138.4; 134.4; 134.3; 
130.2;  129.7; 129.3; 127.6; 119.9; 116.9; 21.6. 
2-(4-nitrophenyl) benzoxazole 4d. Yield 
99%. M.p.: 261-262 oC (Lit.[16] 262-264 oC). 
1H NMR δ 6.81-8.34 (m, 8H, ArH). 
13C NMR δ 
157.5; 152.2; 149.1; 142.5; 137.4; 130.2; 129.0; 
127.3; 124.3; 119.8; 116.8. 
2-(4-hydroxyphenyl) benzoxazole 4e. 
Yield 98%. M.p.: 220-221 oC (Lit.[34] 220-223 
oC). 1H NMR δ 13.78 (s, 1H, OH); 6.83-7.60 
(m, 8H, ArH). 13C NMR δ 162.1; 151.6; 135.4; 
133.3; 132.8; 130.5; 129.7; 129.1; 128.5; 124.5; 
119.2; 116.9.  
2-phenyl benzothiazole 5a. Yield 97%. 
M.p.: 111-113 oC (Lit.[16] 110-114 oC). 1H 
NMR δ 7.42-8.08 (m, 9H, ArH). 13C NMR δ 
167.8; 154.0; 134.9; 133.3; 131.9; 129.9; 127.7; 
126.0; 123.4; 122.2; 114.7. 
 
2-(4-chlorophenyl) benzothiazole 5b. 
Yield 94%. M.p.: 114-116 oC (Lit.[16] 114-116 
oC). 1H NMR δ 7.29-8.11 (m, 8H, ArH). 
13C 
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NMR δ 166.4; 153.9; 136.5; 132.1; 129.9; 
128.7; 127.3; 126.2; 123.4; 122.9, 114.6. 
2-(p-tolyl) benzothiazole 5c. Yield 90%. 
M.p.: 85-87 oC (Lit.[34] 86-89 oC). 1H NMR δ 
7.29-8.06 (m, 8H, ArH); 2.33 (s, 3H, CH3). 
13C 
NMR δ 167.8; 154.1; 141.9; 134.8; 130.7; 
130.3; 127.5; 127.0; 125.8; 123.1; 114.8; 21.4. 
2-(4-nitrophenyl) benzothiazole 5d. Yield 
99%. M.p.: 226-227 oC (Lit.[16] 227-229 oC). 
1H NMR δ 6.51-8.21 (m, 8H, ArH). 
13C NMR δ 
159.4; 149.7; 148.3; 141.7; 132.2; 130.3; 128.8; 
127.6; 124.9;  122.9; 115.1. 
 
Typical experimental procedure for the 
preparation of 3,4-dihydropyrimidin-2(1H)-
ones/thiones 8: A mixture of thiourea or urea 
(1.5 mmol), aldehyde (1 mmol), -ketoester (1 
mmol) and 2 mol % (5.20 mg) of 
NH3(CH2)6NH3SiF6  in ethanol (1 ml) was 
stirred at 100°C for a specified time (Table 6) . 
The progress of the reaction was monitored by 
thin layer chromatography (TLC). The resulted 
reaction mixture was cooled to room 
temperature, diluted with ethanol (2 x 10 mL) 
and stirred for 5 min. Then, the catalyst was 
separated by simple filtration, the solvent was 
evaporated and recrystallized from ethanol to 
afford pure 3,4-dihydropyrimidin-2(1H)-
ones/thiones 8 as yellow/white solids. The 
catalyst from filtrate was recovered by the 
procedure mentioned below. 
5-acetyl-6-methyl-4-phenyl-3,4 dihydro 
pyrimidin-2(1H)-one 8a. Yield 95%. M.p.: 237-
239°C (lit.[38] 238-239°C). 1H NMR δ 9.16 (s, 
1H, NH); 7.71 (s, 1H, NH); 7.20-7.30 ( m, 5H, 
ArH ); 5.12 (d, 1H, J = 3 Hz, CH); 2.22 (s, 3H, 
CH3).  
13C NMR δ 165.0; 152.6; 148.8; 145.5; 
129.0; 127.7; 126.8; 99.7; 54.4; 30.7; 19.5. 
Ethyl 6-methyl-2-oxo-4-phenyl-1,2,3,4-
tetrahydropyrimidine-5-carboxylate 8b. Yield 
90%. M.p.: 208-210°C (lit.[36] 207-208°C). 1H 
NMR δ 9.16 (s, 1H, NH); 7.71 (s, 1H, NH); 
7.21-7.32 (m, 5H, ArH); 5.12 (s, 1H, CH); 3.97 
(q, 2H, OCH2); 2.22 (s, 3H, CH3); 1.1 (t, 3H, 
OCH2CH3). 
13C NMR δ 165.8; 152.6; 145.4; 
129.0; 128.8; 127.7; 126.8;  99.7; 59.6; 54.4; 
17.6; 14.5. 
Ethyl 4-(4-chlorophenyl)-6-methyl-2-oxo 
1,2,3,4-tetrahydropyrimidine-5-carboxylate 8c. 
Yield 91%. M.p.: 212-214°C (lit.[35] 212-
214°C). 1H NMR δ 9.28 (s, 1H, NH); 7.73 (s, 
1H, NH); 7.09-7.55 (m, 4H, ArH); 5.57 (s, 1H, 
CH); 3.89 (q, 2H, OCH2); 2.27 (s, 3H, CH3); 
0.98 (t, 3H, OCH2CH3). 
13C NMR δ 151.6; 
150.0; 141.4; 133.1; 130.7; 129.2; 128.4; 97.9; 
59.6; 51.6; 18.1; 14.3. 
Ethyl 4-(4-chlorophenyl)-6-methyl-2-thio -
xo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 
8d. Yield 90%. M.p.: 186-188°C (lit.[37] 186-
188°C). 1H NMR δ 9.22 (s, 1H, NH); 7.75 (s, 
1H, NH); 7.21-7.38 (m, 4H, ArH); 5.12 (s, 1H, 
CH); 3.97 (q, 2H, OCH2); 2.22 (s, 3H, CH3); 
1.07 (t, 3H, OCH2CH3). 
13C NMR δ 165.7; 
152.4; 149.2; 144.2; 132.0; 128.8; 128.6; 99.3; 
59.7; 53.8; 18.2; 14.5. 
Ethyl 6-methyl-4-(4-nitrophenyl)-2-oxo-
1,2,3,4-tetrahydropyrimidine-5-carboxylate 8e. 
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Yield 99%. M.p.: 210-212°C (lit.[35] 211-
212°C). 1H NMR δ 9.32 (s, 1H, NH); 7.86 (s, 
1H, NH); 7.47-7.56 (m, 4H, ArH); 5.26 (s, 1H, 
CH); 3.97 (q, 2H, OCH2); 2.24 (s, 3H, CH3); 
1.09 (t, 3H, OCH2CH3). 
13C NMR δ 165.5; 
158.1; 152.4; 149.8;  139.5; 130.7;  124.3; 98.6; 
59.9; 54.1; 18.3; 14.5. 
Ethyl 4-(4-methoxyphenyl)-6-methyl-2-
oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 
8f Yield 98%. M.p.: 200-202°C (lit.[39] 200-
202°C).  1H NMR δ 9.10 (s, 1H, NH); 7.64 (s, 
1H, NH); 6.83-7.13 (m, 4H, ArH); 5.07 (s, 1H, 
CH); 3.96 (q, 2H, OCH2); 3.69 (s, 3H, OCH3); 
2.21 (s, 3H, CH3); 1.07 (t, 3H, OCH2CH3). 
13C 
NMR δ 165.9; 158.9; 152.6; 148.4; 137.5; 
127.8; 114.2; 100.1; 59.6; 55.5; 53.8; 18.2; 14.5. 
Ethyl 4-(4-methoxyphenyl)-6-methyl-2-
thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxyl- 
ate 8g Yield 95%. M.p.: 153-155°C (lit.[39] 
153°C).  1H NMR δ 9.11 (s, 1H, NH); 7.63 (s, 
1H, NH); 6.83-7.13 (m, 4H, ArH); 5.07 (s, 1H, 
CH); 3.96 (q, 2H, OCH2); 3.69 (s, 3H, OCH3); 
2.21 (s, 3H, CH3); 1.1 (t, 3H, OCH2CH3). 
13C 
NMR δ 165.8; 158.9; 152.6; 148.4; 137.5; 
127.9; 114.2; 100.1; 59.6; 55.5; 53.8; 18.2; 14.5. 
Ethyl 4-(4-(dimethylamino)phenyl)-6-
methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-
carboxylate 8h. Yield 92%. M.p.: 228-230°C 
(lit.[39] 228-230°C). 1H NMR δ 9.05 (s, 1H, 
NH); 7.68 (s, 1H, NH); 6.61-7.56 (m, 4H, ArH); 
5.01 (s, 1H, CH); 3.97 (q, 2H, OCH2); 3.02 (s, 
3H, NCH3); 3.02 (s, 3H, NCH3); 2.20 (s, 3H, 
CH3); 1.11 (t, 3H, OCH2CH3). 
13C NMR δ 
190.3; 165.9; 152.7; 150.2; 147.9; 133.1; 127.3; 
112.7; 111.5; 100.4; 59.6; 53.7; 18.2; 14.6. 
 
General procedure for the preparation of 
quinoxalines 10: Aldehyde (1 mmol),               
o-phenylenediamine (1 mmol) and 1 mol % 
(2.60 mg) of NH3 (CH2)6NH3SiF6 were stirred 
in methanol (1 ml), at room temperature for the 
appropriate time (Table 8). The progress of the 
reaction was monitored by thin layer 
chromatography (TLC). After completion of the 
reaction, the crude reaction mixture was 
dissolved in ethyl acetate and the catalyst was 
separated out by simple filtration. The 
quinoxalines 10 were recrystallized from 
ethanol. 
2,3-diphenylquinoxaline 10a. Yield 93%. 
M.p.: 126-128°C (lit.[40] 126-127°C).  1H NMR 
δ 7.32-7.37 (m, 6H); 7.43-7.46 (m, 4H); 7.83-
7.86 (m, 2H); 8.11-8.14 (m, 2H).  13C NMR δ 
153.5; 140.9; 139.2; 132.0; 130.9; 130.2; 129.2; 
128.5. 
6-methyl-2,3-diphenylquinoxaline 10b. 
Yield 94%. M.p.: 122-124°C (lit.[40] 120-
122°C).  1H NMR δ 2.47 (s, 3H); 7.28-7.44 (m, 
5H); 7.44-7.66 (m, 4H); 7.66-7.69 (m, 2H); 
7.90-7.99 (m, 2H). 13C NMR δ 153.3; 141.0; 
139.3; 133.0; 130.1; 129.1; 128.8;127.9; 21.8. 
6-nitro-2,3-diphenylquinoxaline 10c. 
Yield 99%. M.p.: 140-142 °C (lit.[40] 140-142 
°C).  1H NMR δ 7.32-7.49 (m, 5H); 8.29-8.32 
(m, 4H); 8.48-8.52 (m, 2H); 8.85-8.86 (m, 2H). 
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13C NMR δ 156.5;  143.4; 139.6; 138.4; 136.0; 
131.2; 130.2; 129.9; 125.3. 
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